Richard Sturgess

Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial

Tim Meyer, Richard Fox, Yuk Ting et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 482 citations · Full text

Updated guideline on the management of common bile duct stones (CBDS)

Earl Williams, Ian J. Beckingham, Ghassan El Sayed et al. · Gut · 2017 · 442 citations · Full text

Wheat peptide challenge in coeliac disease

Richard Sturgess, Phillip Day, H J Ellis et al. · The Lancet · 1994 · 259 citations

Autoimmune Disease, Wheat Peptide Challenge, Pathogenesis +5

The effect of neoadjuvant chemotherapy on physical fitness and survival in patients undergoing oesophagogastric cancer surgery

Sandy Jack, Malcolm West, David Raw et al. · European Journal of Surgical Oncology · 2014 · 177 citations

Surgical Oncology, Esophageal Cancer, Gastrointestinal Oncology +9

Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

Marco Carbone, Alessandra Nardi, Steve Flack et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 158 citations · Full text

Hepatology, Pretreatment Prediction, Biliary Tract +7